Antimicrobial resistance profiles of Staphylococcus epidermidis septicemia in Vietnamese cancer patients
Main Article Content
Abstract
Staphylococcus epidermidis is an important cause of bloodstream infections and a cause of morbidity and mortality in cancer patients. The antimicrobial resistance profiles of S. epidermidis septicemia in Vietnamese cancer patients are limited. We surveyed all S. epidermidis blood culture isolates from Vietnamese cancer patients at the Tan Trieu National Cancer Hospital, from 2020 to 2024. A total of 11 S. epidermidis isolates were identified and antibiotic susceptibility testing was employed. Methicillin resistance was detected in 4/11 of all isolates; all were sensitive to vancomycin, nitrofurantoin, linezolid, quinupristin-dalfopristin; however, all were resistant to benzylpenicillin, oxacillin; 7/11 of isolates were resistant to clindamycin, erythromycin, and trimethoprim-sulfamethoxazole; All of the isolates (11/11) are multidrug resistance. Vancomycin, nitrofurantoin, linezolid, and quinupristin-dalfopristin are effective antimicrobial agents in treating S. epidermidis septicemia in Vietnamese cancer patients. The high level of methicillin and multidrug resistance limited the therapeutic options in Vietnamese cancer patients are causes of concern.
Article Details
Keywords
S. epidermidis, vancomycin, methicillin, septicemia, Vietnamese, cancer
References
2. Ahmed NH, Baruah FK, Grover RK (2015). "Staphylococcal Blood Stream Infections in Cancer Patients", Ann Med Health Sci Res, 5(3), pp.226-7.
3. Tak V, Mathur P, Lalwani S, Misra MC (2013), "Staphylococcal blood stream infections: epidemiology, resistance pattern and outcome at a level 1 Indian trauma care center", J Lab Physicians, 5(1), pp.46-50.
4. Otto M (2009), "Staphylococcus epidermidis--the 'accidental' pathogen", Nature reviews Microbiology, 7(8), pp.555-67.
5. Obeng-Nkrumah N, Labi AK, Acquah ME, Donkor ES (2015), " Bloodstream infections in patients with malignancies: implications for antibiotic treatment in a Ghanaian tertiary setting", BMC research notes, 8:742.
6. Rabayah R, Alsayed RB, Taha AA, Salameh H, Amer R, Sabateen A, et al (2022), "Microbial spectrum and drug resistance profile in solid malignancies in a large tertiary hospital from Palestine", BMC infectious diseases, 22(1), pp.385.
7. Hellmark B, Unemo M, Nilsdotter-Augustinsson A, Soderquist B (2009), "Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections with special focus on rifampicin and variability of the rpoB gene", Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 15(3), pp.238-44.
8. 8. Martinez-Santos VI, Torres-Anorve DA, Echaniz-Aviles G, Parra-Rojas I, Ramirez-Peralta A, Castro-Alarcon N (2022), "Characterization of Staphylococcus epidermidis clinical isolates from hospitalized patients with bloodstream infection obtained in two time periods", PeerJ, 10:e14030.